Resistance to chemotherapeutic agents has proved to be a major barrier in the clinical management of neoplastic disease. Where an initial response is seen, continued treatment frequently results in the regrowth of tumour cells resistant to that form of therapy and is often associated with a decreased response rate to other treatments. Because of the difficulties involved in the direct study of mechanisms in clinical samples, the generation of drug-resistant cell lines has been used extensively in the study of innate and acquired drug resistance. We have adopted this approach to investigate mechanisms of resistance to folate-based thymidylate synthase (TS) inhibitors.
TS (EC 2.1.1.45) catalyses the de novo synthesis of dTMP by the transfer of a one carbon unit from 5,10-CH2-FH4 to the 5-position of dUMP. The importance of TS activity for DNA synthesis has made this enzyme an attractive target for the design of chemotherapeutic agents. Inhibition of TS by the metabolite FdUMP is considered an important site of action of the chemotherapeutic agent 5-fluorouracil (5-FU). Resistance to 5-FU has been associated with elevated levels of TS in cultured cell lines (Priest and Ledford, 1980; Berger et al., 1985; Jenh et al., 1985) and in combination with leucovorin in a human colorectal tumour (Clark et al., 1987) . The importance of TS inhibition to the overall anti-tumour activity of the fluoropyrimidines has been difficult to establish, however, owing to the incorporation of other fluorinated drug metabolites into RNA (Wilkinson et al., 1975; Kufe and Major, 1981; Glazer and Lloyd, 1982; Herrick and Kufe, 1984) and DNA (Kufe et al., 1981; Saywer et al., 1984) which has been associated with cytotoxicity. More recently, folate analogues have been synthesised which act by forming a tightly bound non-productive complex with TS and the natural substrate dUMP. l0-Propargyl-5,8-dideazafolate (CB3717) was the first folate analogue, designed as an inhibitor of TS (Jones et al., 1981) (Calvert et al.. 1986; Bassendine et al., 1987; Sessa et al., 1988) , but excessive renal toxicity owing to poor solubility at low pH resulted in the withdrawal of this compound from further clinical studies.
ZD1694 has since been chosen as a non-nephrotoxic, highly active successor to CB3717 (Jackman et al., 1991; Jodrell et al., 1991) . ZD1694 is principally active through its polyglutamate forms (Jackman et al., 1991) and is currently being clinically evaluated in phase III trials.
In this study, the human lymphoblastoid cell line W1L2 and the human ovarian carcinoma cell line CHI have been selected for resistance to ZD1694. Using Southern, reverse transcription-polymerase chain reaction and Western techniques we have determined the role of TS expression in determining resistance in these lines. Establishment details and biochemical studies of resistance are described in an accompanying study (Jackman et al., 1995 Results are expressed as target mRNA levels relative to the internal reference standards: 1-actin mRNA and 18S rRNA.
The sequences of the thymidylate synthase (Takeishi et al., 1985) and P-actin (Ng et al., 1985) primers were the same as those used by Horikoshi et al. (1991) : TS-5'(5'-AGA TCC -AAC ACA TCC TCC GCT-3'), TS-3' (5'-CCA GAA CAC ACG TrTT GGT TCT CAG-3'), P-actin-5' (5'-GCG GGA -AAT CGT GCG TGA CAT T-3') and P-actin-3' (5'-GAT GGA GTT GAA GGT AGT TTC GTG-3').
The dihydrofolate reductase (DHFR) mRNA (Chen et al., 1984) and 18S rRNA (Torczynski et al., 1985) primers were selected using the primer selection programme designed by Lowe et al. (1990) : DHFR-5' (5'-CCA CAA CCT-CTT CAG TAG AAG-3'), DHFR-3' (5'-CTT ATT GCC-TTT CTC CTC CTG G-3'), 18S-5' (5'-GAT GGA GTT GAA GGT AGT TTC GTG-3') and 18S-3' (5'-GAA CTA CGA CGG TAT CTG ATC G-3'). All primers were synthesised on an Applied Biosystems 392 DNA/RNA synthesiser. PCR products were separated on 12% polyacrylamide gels. To 10 gl of each PCR reaction, 3 gl of 5 x sample loading buffer was added (10% Ficoll, 0.05% bromophenol blue, 0.25% orange G and 0.5% SDS in water). The acrylamide gels were dried down and radioactive PCR product bands were located by autoradiography for excision and subsequent quantification by liquid scintillation counting. Background control bands from each lane were also excised, and these counts were subtracted from the PCR product band counts. Transcript abundance was calculated by relating target mRNA levels, TS and DHFR, to the internal reference standard levels, P-actin mRNA and 18S RNA.
DNA analysis DNA extractions were carried out either using the Applied Biosystems 340A nucleic acid extractor (Applied Biosystems, CA, USA) or manually. The initial stages for each method are identical. Cell membranes were disrupted by gently mixing the cells with nuclear isolation buffer [NIB: 0.25% of Nonidet P40 (non-ionic detergent), 100 mM sodium chloride, 10 mM Tris-HCI, 1 mM EDTA]. Approximately 2 ml of NIB was used per 108 cells. The nuclei were then spun down for 5 min at 2000 g (4°C) and the supernatant removed. The nuclear pellets were resuspended in the same volume of NIB as before plus a further volume of 2 x lysis buffer (Applied Biosystems product: urea, sodium chloride, n-lauroyl sarcosine and 1,2-cyclohexaminediamine tetra-acetic acid in Tnrs-HCI, pH 7.9) and proteinase K added to a final concentration of 600 gLg ml-'. This mixture was incubated at 60C for 2 h or until the majority of the protein was digested. For the automated process the proteinase K digest is loaded onto the machine which carries out automated phenol-chloroform extractions and isopropanol precipitations. The final DNA precipitate is collected onto a filter from which it can be redissolved in the required solution. For the manual DNA procedure organic extractions were carried out essentially as described by Sambrook et al. (1989) .
For Southern transfer, DNA samples were digested with the restriction endonuclease EcoRP, and the fragments separated by electrophoresis on 0.8% agarose gels before transfer to and immobilisation on nylon membranes. Probe hybridisation was carried out under standard conditions at 65'C with a final wash stringency of 2 x standard saline citrate (1 x = 0.15 M sodium chloride, 0.015 M sodium citrate, pH 7.0) and 0.2% sodium dodecyl sulphate (SDS). The probe used for TS DNA and mRNA analysis was a 0.7 kb gel-purified fragment of mouse TS cDNA cleaved from the pMTS-3 plasmid with HindIIl and PstI (Geyer and Johnson, 1984) which was 32P labelled by random primer extension (Feinberg and Vogelstein, 1983) . Equal loading of DNA was determined by ethidium bromide staining of the gels before transfer. A non-amplified cross-reacting sequence was evident in all the samples probed with the TS cDNA probe, and this was also used to check for equal DNA loading. This sequence has been previously reported (Berger et al., 1985; Clark et al., 1987) with the suggestion that this sequence is a TS pseudogene which exists at an alternative chromosomal location (Clark et al., 1987) . To estimate the degree of TS gene amplifcation, dilutions of the resistant cell line DNA and RNA samples were made to obtain a signal of equal intensity to that produced by undiluted parental DNA. The membranes were exposed to X-ray film at -70°C with intensifying screens and for quantification of signals the filters were analysed using the Phosphorlmager system (Molecular Dynamics, Sunnyvale, CA, USA).
Reits
For detailed cell characterisation see the accompanying paper by Jackman et al. in this issue. Briefly, the W1L2:R cell line was >20000-fold resistant and the CHI:R cell line was approximately 14-fold resistant to ZD1694. There was an increase in TS activity in both cell lines (WlL2:R, 514-fold; and CHI:R, 4.2-fold). There were no significnt differences in DHFR activity.
Protein analysis
The Western blots in Figure 1 demonstrate the different levels of TS protein in the resistant vs parental cell lines.
Using the Phosphorlmager the relative amount of 'I-labelled protein A was quantified in the bands corresponding to the molecular weight of the human TS monomer (36 kDa). The results from this analysis and from two repeat experiments show that the total TS protein level in CHI:R cells was approximately 2.5-fold higher than that of the parental cell line. TS protein determinations using the W1L2 and WIL2:R cell lines (Figure lb) indicated that the level of TS monomer in the resistant cells was elevated by approximately 1000-, 600-and 500-fold from three separate experiments. Figure 2 shows the Southern analysis for TS with DNA from the W1L2 and WIL2:R cell lines. The Phosphorlmager was used to quantify the relative amounts of radioactivity in each band and the difference in TS gene copy number between the cell lnes was calculated. The increase in TS gene copy number in the WIL2:R compared with the W1L2 cell line, calclated from this blot, was 114-fold with a 95% confidence interval of 66-to 162-fold (P = 0.009). In two repeats of this analysis (not shown) the increase in TS gene copy number in the WIL2:R cell ie appeared to be approximately 60-to 100-fold. Figure 3 shows the Southern analysis for TS gene copy levels for the CHI and CHI:R cell line. The taied t-test (P = 0.0378). A similar increase was seen when TS mRNA levels were expressed relative to DHFR mRNA and 18S rRNA levels, but this did not achieve signif .
DNA analysis
There was no significant difference in the P-actin/18S expression ratios between the CHI and CHL:R cell lines. Northern analysis using total RNA from these cell lines (not shown) suggested that there was a small increase (approximately 2-fold) in TS mRNA levels in the resistant cell line. The sum of the mean values from the three TS expression ratios (relative to DHFR, P-actin and 18S) indicates that the increase in TS mRNA level, although small (approximately 2-fold), does achieve statistical signice (P = 0.0179). The results from the W1L2:R and CH1:R cell lines are summarised in Table II. In both of the cell lines studied, the increase in the level of resistance obtained to the selective agent exceeds the increases in the TS gene copy number, mRNA, protein or catalytic activity levels determined. In the CH1:R cell line the increase in TS gene copy number was associated with a similar increase in TS mRNA and protein; in the W1L2:R cell line the increase in TS protein levels and activity exceeds that of the increase in gene copy and mRNA levels by at least 4-fold.
Two cell lines selected for the ability to grow in high levels of the folate-based TS inhibitor, ZD1694, were studied to determine their mechanisms of resistance. Initial studies revealed increases m TS catalytic activity in both cell lines, and we found that this was associated with TS gene amplification and overexpression and not with an alteration in the enzyme itself. Neither of the resistant cell lines showed evidence of gene rearrangement involving the EcoRI fragment detected by Southern blot analysis. This, together with the proportionate increase in TS mRNA levels and maintenance of the normal transcript sizes in the cell lines, strongly suggested that the amplified TS genes were intact and transcriptionally active. The regions of DNA which contain amplified genes (amplicons) for other genetic markers are reported to range in size from approximately 50 kb to >10 Mb, which could comfortably contain the full 16 kb of the biologically active TS sequence (Kaneda et al., 1990) .
The most common biochemical alterations associated with acquired resistance to the antifolate methotrexate (MTX) are overexpression of the target enzyme DHFR (Biedler and Spengler, 1975, 1976; Kaufman, 1979; Flintoff et al., 1982) , altered drug transport (Schuetz et al., 1988; Norris et al., 1991; Trippett et al., 1992) and altered drug polyglutamation (McCloskey et al., 1991; Van der Laan et al., 1991) . This pattern would appear to apply equally to the folate-based TS inhibitor, 21694; cell lines selected for resistance to ZD1694 have also demonstrated these three manifestations of resistance (accompanying study; Jackman et al., 1995).
There were no significant differences in DHFR enzyme activity or transcript levels between the parental cells and the ZD1694-resistant variants. This contrasts with the murine L1210:C15 cell line, selected for a high level of resistance to the TS inhibitor CB3717, which has been reported to have approximately 45-fold increased TS gene copy number and mRNA levels plus a 30-to 40-fold increase in DHFR gene copy number with a 7-fold elevation of DHFR mRNA levels (Imam et al., 1987) . As DHFR was not overexpressed in either cell line selected for resistance to ZD1694, it does not seem to be a prerequisite for cell lines resistant to high levels of folate-based TS inhibitors to overexpress the DHFR gene with the TS gene.
In both of the cell lines described in this study the fold resistance exceeds the fold increase in TS gene copy number, mRNA and protein levels. Possible explanations relating to altered transport or polyglutamination are addressed in an accompanying study (Jackman et al., 1995 three recent reports that translational mechanisms are involved in the regulation of T1S expression (Kaneda et al., 1987; Chu et al., 1991; Keyomarsi et al., 1993) . Differences in the naturally occurring levels of 1T3 and any changes in these levels subsequent to drug administration may be crifical determinants of clinical response to these agents. Keyomarsi et al. (1993) have reported that, following ZD1694 treatment, TS activity, but not mRNA kvels, increases by up to 40-fold in normal and lO4old in tumourderived cell lines, suggesting a loss of TS tanslational regulation in the presence of ZD1694. The importance of TS kwels to the cytotoxicity of these compounds in vitro is demonstrated by the cell lines described in this report. For future consideration it will be of interest to relate innate TS kwls to the activity of these compounds in vitro, in vivo and in the clinic. Amwybi. 5, 10CHrFH4, 5, 10ncthyiene 
